ID	Gene Name	Species	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KW_BIOLOGICAL_PROCESS	UP_KW_CELLULAR_COMPONENT	UP_KW_DISEASE	UP_KW_DOMAIN	UP_KW_LIGAND	UP_KW_MOLECULAR_FUNCTION	UP_KW_PTM	UP_SEQ_FEATURE
Q9CWK3	CD2 cytoplasmic tail binding protein 2(Cd2bp2)	Mus musculus		GO:0006397~mRNA processing,GO:0008380~RNA splicing,	GO:0001650~fibrillar center,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005682~U5 snRNP,GO:0005829~cytosol,GO:0016607~nuclear speck,	GO:0043021~ribonucleoprotein complex binding,	IPR003169:GYF,IPR035445:GYF-like_dom_sf,IPR039905:CD2BP2/Lin1,				SM00444:GYF,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0963~Cytoplasm,					KW-0007~Acetylation,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	COMPBIAS:Basic and acidic residues,CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2),DOMAIN:GYF,REGION:Disordered,
A7S2N8	E3 UFM1-protein ligase 1 homolog(LOC5513886)	Nematostella vectensis		GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0034976~response to endoplasmic reticulum stress,GO:1990592~protein K69-linked ufmylation,	GO:0005789~endoplasmic reticulum membrane,	GO:0061666~UFM1 ligase activity,GO:0071568~UFM1 transferase activity,	IPR018611:Ufl1,					KW-0833~Ubl conjugation pathway,					KW-0808~Transferase,		COMPBIAS:Basic and acidic residues,REGION:Disordered,
Q7RTR2	NLR family CARD domain containing 3(NLRC3)	Homo sapiens		GO:0007249~canonical NF-kappaB signal transduction,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032687~negative regulation of interferon-alpha production,GO:0032688~negative regulation of interferon-beta production,GO:0032715~negative regulation of interleukin-6 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0035556~intracellular signal transduction,GO:0042110~T cell activation,GO:0043124~negative regulation of canonical NF-kappaB signal transduction,GO:0045824~negative regulation of innate immune response,GO:0048147~negative regulation of fibroblast proliferation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050728~negative regulation of inflammatory response,GO:0051898~negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,GO:1900016~negative regulation of cytokine production involved in inflammatory response,GO:1900226~negative regulation of NLRP3 inflammasome complex assembly,GO:1901223~negative regulation of non-canonical NF-kappaB signal transduction,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034451~centriolar satellite,GO:0043231~intracellular membrane-bounded organelle,GO:0048471~perinuclear region of cytoplasm,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,	IPR001611:Leu-rich_rpt,IPR007111:NACHT_NTPase,IPR027417:P-loop_NTPase,IPR032675:LRR_dom_sf,IPR041075:NOD1/2_WH,IPR041267:NLRP_HD2,IPR051261:NLR,IPR052201:LRR-containing_regulator,				SM00368:LRR_RI,		KW-0963~Cytoplasm,		KW-0433~Leucine-rich repeat,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			DOMAIN:NACHT,MOTIF:TRAF6-binding,MUTAGEN:SLQE->AAAA: Strong decrease of TRAF6-binding.,MUTAGEN:SVEE->AAAA: Almost no effect on TRAF6-binding.,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
P59046	NLR family pyrin domain containing 12(NLRP12)	Homo sapiens		GO:0001818~negative regulation of cytokine production,GO:0006915~apoptotic process,GO:0007165~signal transduction,GO:0009968~negative regulation of signal transduction,GO:0031953~negative regulation of protein autophosphorylation,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032661~regulation of interleukin-18 production,GO:0032692~negative regulation of interleukin-1 production,GO:0032715~negative regulation of interleukin-6 production,GO:0032731~positive regulation of interleukin-1 beta production,GO:0036336~dendritic cell migration,GO:0043122~regulation of canonical NF-kappaB signal transduction,GO:0043124~negative regulation of canonical NF-kappaB signal transduction,GO:0045345~positive regulation of MHC class I biosynthetic process,GO:0045751~negative regulation of Toll signaling pathway,GO:0050727~regulation of inflammatory response,GO:0050728~negative regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0070371~ERK1 and ERK2 cascade,GO:0070373~negative regulation of ERK1 and ERK2 cascade,GO:0071345~cellular response to cytokine stimulus,GO:1901223~negative regulation of non-canonical NF-kappaB signal transduction,GO:1901224~positive regulation of non-canonical NF-kappaB signal transduction,GO:2000116~regulation of cysteine-type endopeptidase activity,GO:2001056~positive regulation of cysteine-type endopeptidase activity,	GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008656~cysteine-type endopeptidase activator activity involved in apoptotic process,GO:0030674~protein-macromolecule adaptor activity,	IPR001611:Leu-rich_rpt,IPR004020:DAPIN,IPR007111:NACHT_NTPase,IPR011029:DEATH-like_dom_sf,IPR027417:P-loop_NTPase,IPR029495:NACHT-assoc,IPR032675:LRR_dom_sf,IPR041075:NOD1/2_WH,IPR041267:NLRP_HD2,IPR050637:NLRP_innate_immun_reg,	hsa04621:NOD-like receptor signaling pathway,	611762~Familial cold autoinflammatory syndrome 2,		SM00368:LRR_RI,SM01288:FISNA,SM01289:PYRIN,		KW-0963~Cytoplasm,		KW-0433~Leucine-rich repeat,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			DOMAIN:FISNA,DOMAIN:NACHT,DOMAIN:Pyrin,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,
Q86W24	NLR family pyrin domain containing 14(NLRP14)	Homo sapiens		GO:0007283~spermatogenesis,GO:0030154~cell differentiation,GO:0050727~regulation of inflammatory response,	GO:0005737~cytoplasm,	GO:0005524~ATP binding,	IPR001611:Leu-rich_rpt,IPR004020:DAPIN,IPR007111:NACHT_NTPase,IPR011029:DEATH-like_dom_sf,IPR027417:P-loop_NTPase,IPR032675:LRR_dom_sf,IPR041075:NOD1/2_WH,IPR041267:NLRP_HD2,IPR050637:NLRP_innate_immun_reg,				SM00368:LRR_RI,SM01289:PYRIN,	KW-0221~Differentiation,KW-0744~Spermatogenesis,	KW-0963~Cytoplasm,		KW-0433~Leucine-rich repeat,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0217~Developmental protein,KW-9996~Developmental protein,		DOMAIN:NACHT,DOMAIN:Pyrin,MUTAGEN:L->R: Increased thermal stability of the Pyrin domain.,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
A6QLE5	NLR family pyrin domain containing 3(NLRP3)	Bos taurus		GO:0002674~negative regulation of acute inflammatory response,GO:0002830~positive regulation of type 2 immune response,GO:0006954~inflammatory response,GO:0009595~detection of biotic stimulus,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032753~positive regulation of interleukin-4 production,GO:0044546~NLRP3 inflammasome complex assembly,GO:0045087~innate immune response,GO:0045630~positive regulation of T-helper 2 cell differentiation,GO:0045944~positive regulation of transcription by RNA polymerase II,GO:0050729~positive regulation of inflammatory response,GO:0051260~protein homooligomerization,GO:1901223~negative regulation of non-canonical NF-kappaB signal transduction,GO:2000553~positive regulation of T-helper 2 cell cytokine production,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005783~endoplasmic reticulum,GO:0005815~microtubule organizing center,GO:0016020~membrane,GO:0031021~interphase microtubule organizing center,GO:0072559~NLRP3 inflammasome complex,	GO:0005524~ATP binding,GO:0016887~ATP hydrolysis activity,GO:0035591~signaling adaptor activity,GO:0043531~ADP binding,GO:0043565~sequence-specific DNA binding,GO:0070273~phosphatidylinositol-4-phosphate binding,GO:0140297~DNA-binding transcription factor binding,GO:0140299~molecular sensor activity,GO:1901981~phosphatidylinositol phosphate binding,	IPR001611:Leu-rich_rpt,IPR004020:DAPIN,IPR007111:NACHT_NTPase,IPR011029:DEATH-like_dom_sf,IPR027417:P-loop_NTPase,IPR029495:NACHT-assoc,IPR032675:LRR_dom_sf,IPR041075:NOD1/2_WH,IPR041267:NLRP_HD2,IPR050637:NLRP_innate_immun_reg,	bta04217:Necroptosis,bta04621:NOD-like receptor signaling pathway,bta04623:Cytosolic DNA-sensing pathway,bta04625:C-type lectin receptor signaling pathway,bta05132:Salmonella infection,bta05133:Pertussis,bta05135:Yersinia infection,bta05164:Influenza A,bta05171:Coronavirus disease - COVID-19,bta05417:Lipid and atherosclerosis,			SM00368:LRR_RI,SM01288:FISNA,SM01289:PYRIN,	KW-0391~Immunity,KW-0395~Inflammatory response,KW-0399~Innate immunity,KW-0804~Transcription,KW-0805~Transcription regulation,	KW-0206~Cytoskeleton,KW-0256~Endoplasmic reticulum,KW-0333~Golgi apparatus,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0539~Nucleus,KW-0963~Cytoplasm,KW-0964~Secreted,KW-1271~Inflammasome,	KW-1008~Amyloidosis,	KW-0433~Leucine-rich repeat,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0010~Activator,KW-0378~Hydrolase,	KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0597~Phosphoprotein,KW-0832~Ubl conjugation,KW-1017~Isopeptide bond,	CROSSLNK:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),DOMAIN:FISNA,DOMAIN:NACHT,DOMAIN:Pyrin,LIPID:S-palmitoyl cysteine,MOTIF:KFERQ-like motif 1,MOTIF:KFERQ-like motif 2,MOTIF:KFERQ-like motif 3,MOTIF:KFERQ-like motif 4,REGION:Required for binding to phosphatidylinositol 4-phosphate (PtdIns4P),REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
C3VPR6	NLR family, CARD domain containing 5(Nlrc5)	Mus musculus		GO:0009617~response to bacterium,GO:0010646~regulation of cell communication,GO:0023051~regulation of signaling,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0035556~intracellular signal transduction,GO:0043549~regulation of kinase activity,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0045345~positive regulation of MHC class I biosynthetic process,GO:0045944~positive regulation of transcription by RNA polymerase II,GO:0051607~defense response to virus,GO:0060335~positive regulation of type II interferon-mediated signaling pathway,GO:0060339~negative regulation of type I interferon-mediated signaling pathway,GO:0060340~positive regulation of type I interferon-mediated signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0005829~cytosol,	GO:0000978~RNA polymerase II cis-regulatory region sequence-specific DNA binding,GO:0005524~ATP binding,	IPR001611:Leu-rich_rpt,IPR003591:Leu-rich_rpt_typical-subtyp,IPR006553:Leu-rich_rpt_Cys-con_subtyp,IPR007111:NACHT_NTPase,IPR027417:P-loop_NTPase,IPR032675:LRR_dom_sf,IPR041210:NLRC5_atypical_Card,IPR041267:NLRP_HD2,IPR051261:NLR,				SM00367:LRR_CC,SM00368:LRR_RI,SM00369:LRR_TYP,	KW-0391~Immunity,KW-0399~Innate immunity,	KW-0963~Cytoplasm,		KW-0433~Leucine-rich repeat,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,			DOMAIN:NACHT,REGION:Disordered,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 11,REPEAT:LRR 12,REPEAT:LRR 13,REPEAT:LRR 14,REPEAT:LRR 15,REPEAT:LRR 16,REPEAT:LRR 17,REPEAT:LRR 18,REPEAT:LRR 19,REPEAT:LRR 2,REPEAT:LRR 20,REPEAT:LRR 21,REPEAT:LRR 22,REPEAT:LRR 23,REPEAT:LRR 24,REPEAT:LRR 25,REPEAT:LRR 26,REPEAT:LRR 27,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
Q7Z494	NPHP3-ACAD11 readthrough (NMD candidate)(NPHP3-ACAD11)	Homo sapiens		GO:0001822~kidney development,GO:0001947~heart looping,GO:0003283~atrial septum development,GO:0006629~lipid metabolic process,GO:0007163~establishment or maintenance of cell polarity,GO:0007368~determination of left/right symmetry,GO:0016055~Wnt signaling pathway,GO:0030198~extracellular matrix organization,GO:0030324~lung development,GO:0035469~determination of pancreatic left/right asymmetry,GO:0045494~photoreceptor cell maintenance,GO:0048496~maintenance of animal organ identity,GO:0060026~convergent extension,GO:0060027~convergent extension involved in gastrulation,GO:0060271~cilium assembly,GO:0060287~epithelial cilium movement involved in determination of left/right asymmetry,GO:0060993~kidney morphogenesis,GO:0071908~determination of intestine left/right asymmetry,GO:0071909~determination of stomach left/right asymmetry,GO:0071910~determination of liver left/right asymmetry,GO:0072189~ureter development,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1905515~non-motile cilium assembly,GO:2000095~regulation of Wnt signaling pathway, planar cell polarity pathway,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005929~cilium,GO:0097543~ciliary inversin compartment,GO:0097546~ciliary base,		IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR027417:P-loop_NTPase,IPR051787:Effector/Ciliary-Dev_Assoc,IPR052752:NACHT-WD_repeat,				SM00028:TPR,	KW-0879~Wnt signaling pathway,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,	KW-0225~Disease variant,KW-0981~Meckel syndrome,KW-0983~Nephronophthisis,KW-1186~Ciliopathy,	KW-0175~Coiled coil,KW-0677~Repeat,KW-0802~TPR repeat,		KW-0505~Motor protein,	KW-0449~Lipoprotein,KW-0519~Myristate,	COMPBIAS:Polar residues,LIPID:N-myristoyl glycine,REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 10,REPEAT:TPR 11,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,REPEAT:TPR 9,
Q5ZID0	NmrA like redox sensor 1(NMRAL1)	Gallus gallus			GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0048471~perinuclear region of cytoplasm,	GO:0042802~identical protein binding,	IPR008030:NmrA-like,IPR036291:NAD(P)-bd_dom_sf,IPR051164:NmrA-like_oxidored,						KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0521~NADP,			DOMAIN:NmrA-like,
Q6ZRS2	Snf2 related CREBBP activator protein(SRCAP)	Homo sapiens		GO:0006338~chromatin remodeling,GO:0006355~regulation of DNA-templated transcription,GO:0006357~regulation of transcription by RNA polymerase II,GO:0045893~positive regulation of DNA-templated transcription,	GO:0000786~nucleosome,GO:0000812~Swr1 complex,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005794~Golgi apparatus,GO:0016604~nuclear body,GO:0032991~protein-containing complex,GO:0048471~perinuclear region of cytoplasm,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0004386~helicase activity,GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATP hydrolysis activity,GO:0042393~histone binding,GO:0140658~ATP-dependent chromatin remodeler activity,	IPR000330:SNF2_N,IPR001650:Helicase_C-like,IPR014001:Helicase_ATP-bd,IPR014012:HSA_dom,IPR017956:AT_hook_DNA-bd_motif,IPR027417:P-loop_NTPase,IPR038718:SNF2-like_sf,IPR049730:SNF2/RAD54-like_C,IPR050520:INO80/SWR1_helicase,	hsa03082:ATP-dependent chromatin remodeling,	136140~Floating-Harbor syndrome,619595~Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities,		SM00384:AT_hook,SM00487:DEXDc,SM00490:HELICc,SM00573:HSA,	KW-0804~Transcription,KW-0805~Transcription regulation,KW-0945~Host-virus interaction,	KW-0539~Nucleus,	KW-0225~Disease variant,KW-0991~Intellectual disability,	KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,	KW-0010~Activator,KW-0156~Chromatin regulator,KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,DNA_BIND:A.T hook 1,DNA_BIND:A.T hook 2,DNA_BIND:A.T hook 3,DOMAIN:HSA,DOMAIN:Helicase ATP-binding,DOMAIN:Helicase C-terminal,REGION:Disordered,
Q8C1B2	TCDD-inducible poly(ADP-ribose) polymerase(Tiparp)	Mus musculus		GO:0001570~vasculogenesis,GO:0001822~kidney development,GO:0007588~excretion,GO:0008152~metabolic process,GO:0008209~androgen metabolic process,GO:0008210~estrogen metabolic process,GO:0008585~female gonad development,GO:0009791~post-embryonic development,GO:0010629~negative regulation of gene expression,GO:0030097~hemopoiesis,GO:0045732~positive regulation of protein catabolic process,GO:0048008~platelet-derived growth factor receptor signaling pathway,GO:0048705~skeletal system morphogenesis,GO:0048745~smooth muscle tissue development,GO:0060021~roof of mouth development,GO:0060325~face morphogenesis,GO:0071407~cellular response to organic cyclic compound,GO:1904612~response to 2,3,7,8-tetrachlorodibenzodioxine,	GO:0005634~nucleus,	GO:0000987~cis-regulatory region sequence-specific DNA binding,GO:0003950~NAD+-protein poly-ADP-ribosyltransferase activity,GO:0016779~nucleotidyltransferase activity,GO:0046872~metal ion binding,GO:0140803~NAD+-protein-cysteine ADP-ribosyltransferase activity,GO:0140806~NAD+-protein-aspartate ADP-ribosyltransferase activity,GO:0140822~NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity,GO:0140844~NAD+-histone H2BE2 glutamate ADP-ribosyltransferase activity,GO:0140867~NAD+-histone H2BE18 glutamate ADP-ribosyltransferase activity,GO:1990404~NAD+-protein ADP-ribosyltransferase activity,	IPR000571:Znf_CCCH,IPR004170:WWE_dom,IPR012317:Poly(ADP-ribose)pol_cat_dom,IPR037197:WWE_dom_sf,IPR051712:ARTD-AVP,						KW-0539~Nucleus,		KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0520~NAD,KW-0862~Zinc,	KW-0328~Glycosyltransferase,KW-0548~Nucleotidyltransferase,KW-0808~Transferase,	KW-0013~ADP-ribosylation,	DOMAIN:C3H1-type,DOMAIN:PARP catalytic,DOMAIN:WWE,MOTIF:Nuclear localization signal,REGION:Disordered,ZN_FING:C3H1-type,
Q5ND34	WD repeat domain 81(Wdr81)	Mus musculus		GO:0006511~ubiquitin-dependent protein catabolic process,GO:0007005~mitochondrion organization,GO:0035973~aggrephagy,GO:0045022~early endosome to late endosome transport,GO:0050821~protein stabilization,	GO:0000421~autophagosome membrane,GO:0005739~mitochondrion,GO:0005765~lysosomal membrane,GO:0005829~cytosol,GO:0010008~endosome membrane,GO:0031901~early endosome membrane,GO:0031902~late endosome membrane,	GO:0035014~phosphatidylinositol 3-kinase regulator activity,GO:0070530~K63-linked polyubiquitin modification-dependent protein binding,GO:0141039~phosphatidylinositol 3-kinase inhibitor activity,	IPR000409:BEACH_dom,IPR001680:WD40_rpt,IPR011009:Kinase-like_dom_sf,IPR015943:WD40/YVTN_repeat-like_dom_sf,IPR036322:WD40_repeat_dom_sf,IPR036372:BEACH_dom_sf,IPR052651:WDR81,				SM00320:WD40,SM01026:Beach,		KW-0458~Lysosome,KW-0472~Membrane,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-0967~Endosome,KW-0968~Cytoplasmic vesicle,		KW-0677~Repeat,KW-0809~Transit peptide,KW-0853~WD repeat,				COMPBIAS:Acidic residues,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:BEACH,MUTAGEN:L->P: Progressive ataxia associated with Purkinje cell death. Retinal thinning due to photoreceptor cell death.,REGION:Disordered,REGION:Necessary and sufficient for the interaction with SQSTM1,REPEAT:WD,REPEAT:WD 1,REPEAT:WD 2,REPEAT:WD 3,REPEAT:WD 4,REPEAT:WD 5,
A6NFN9	ankyrin repeat and ubiquitin domain containing 1(ANKUB1)	Homo sapiens					IPR000626:Ubiquitin-like_dom,IPR002110:Ankyrin_rpt,IPR029071:Ubiquitin-like_domsf,IPR036770:Ankyrin_rpt-contain_sf,IPR042788:ANKUB1,				SM00248:ANK,
Q5ZLC8	ankyrin repeat domain 52(ANKRD52)	Gallus gallus	General function prediction only,	GO:0036371~protein localization to T-tubule,GO:0055117~regulation of cardiac muscle contraction,GO:1904108~protein localization to ciliary inversin compartment,	GO:0030315~T-tubule,GO:0097543~ciliary inversin compartment,	GO:0005515~protein binding,	IPR002110:Ankyrin_rpt,IPR036770:Ankyrin_rpt-contain_sf,IPR050745:Multifunctional_regulatory,				SM00248:ANK,				KW-0040~ANK repeat,KW-0677~Repeat,				REPEAT:ANK,REPEAT:ANK 1,REPEAT:ANK 10,REPEAT:ANK 11,REPEAT:ANK 12,REPEAT:ANK 13,REPEAT:ANK 14,REPEAT:ANK 15,REPEAT:ANK 16,REPEAT:ANK 17,REPEAT:ANK 18,REPEAT:ANK 19,REPEAT:ANK 2,REPEAT:ANK 20,REPEAT:ANK 21,REPEAT:ANK 22,REPEAT:ANK 23,REPEAT:ANK 24,REPEAT:ANK 25,REPEAT:ANK 26,REPEAT:ANK 27,REPEAT:ANK 28,REPEAT:ANK 3,REPEAT:ANK 4,REPEAT:ANK 5,REPEAT:ANK 6,REPEAT:ANK 7,REPEAT:ANK 8,REPEAT:ANK 9,
Q9P0X4	calcium voltage-gated channel subunit alpha1 I(CACNA1I)	Homo sapiens		GO:0007165~signal transduction,GO:0019228~neuronal action potential,GO:0030431~sleep,GO:0070588~calcium ion transmembrane transport,GO:0098703~calcium ion import across plasma membrane,	GO:0005886~plasma membrane,GO:0005891~voltage-gated calcium channel complex,	GO:0005245~voltage-gated calcium channel activity,GO:0005515~protein binding,GO:0008331~high voltage-gated calcium channel activity,	IPR002077:VDCCAlpha1,IPR005445:VDCC_T_a1,IPR005821:Ion_trans_dom,IPR027359:Volt_channel_dom_sf,IPR043203:VGCC_Ca_Na,	hsa04010:MAPK signaling pathway,hsa04020:Calcium signaling pathway,hsa04713:Circadian entrainment,hsa04925:Aldosterone synthesis and secretion,hsa04927:Cortisol synthesis and secretion,hsa04929:GnRH secretion,hsa04934:Cushing syndrome,	620114~Neurodevelopmental disorder with speech impairment and with or without seizures,			KW-0109~Calcium transport,KW-0406~Ion transport,KW-0813~Transport,	KW-0472~Membrane,	KW-0225~Disease variant,KW-0991~Intellectual disability,	KW-0677~Repeat,KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0106~Calcium,	KW-0107~Calcium channel,KW-0407~Ion channel,KW-0851~Voltage-gated channel,	KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,COMPBIAS:Pro residues,REGION:Disordered,REPEAT:I,REPEAT:II,REPEAT:III,REPEAT:IV,SITE:Calcium ion selectivity and permeability,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical; Name=S1 of repeat I,TRANSMEM:Helical; Name=S1 of repeat II,TRANSMEM:Helical; Name=S1 of repeat III,TRANSMEM:Helical; Name=S1 of repeat IV,TRANSMEM:Helical; Name=S2 of repeat I,TRANSMEM:Helical; Name=S2 of repeat II,TRANSMEM:Helical; Name=S2 of repeat III,TRANSMEM:Helical; Name=S2 of repeat IV,TRANSMEM:Helical; Name=S3 of repeat I,TRANSMEM:Helical; Name=S3 of repeat II,TRANSMEM:Helical; Name=S3 of repeat III,TRANSMEM:Helical; Name=S3 of repeat IV,TRANSMEM:Helical; Name=S4 of repeat I,TRANSMEM:Helical; Name=S4 of repeat II,TRANSMEM:Helical; Name=S4 of repeat III,TRANSMEM:Helical; Name=S4 of repeat IV,TRANSMEM:Helical; Name=S5 of repeat I,TRANSMEM:Helical; Name=S5 of repeat II,TRANSMEM:Helical; Name=S5 of repeat III,TRANSMEM:Helical; Name=S5 of repeat IV,TRANSMEM:Helical; Name=S6 of repeat I,TRANSMEM:Helical; Name=S6 of repeat II,TRANSMEM:Helical; Name=S6 of repeat III,TRANSMEM:Helical; Name=S6 of repeat IV,
O02751	craniofacial development protein 2(CFDP2)	Bos taurus			GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003824~catalytic activity,	IPR005135:Endo/exonuclease/phosphatase,IPR027124:Swc5/CFDP1/2,IPR036691:Endo/exonu/phosph_ase_sf,						KW-0539~Nucleus,KW-0963~Cytoplasm,						COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,REGION:Disordered,REGION:Hydrophilic,
Q96F81	dispatched RND transporter family member 1(DISP1)	Homo sapiens		GO:0007224~smoothened signaling pathway,GO:0007225~patched ligand maturation,GO:0007368~determination of left/right symmetry,GO:0009880~embryonic pattern specification,GO:0009953~dorsal/ventral pattern formation,GO:0015833~peptide transport,GO:0050708~regulation of protein secretion,GO:0055085~transmembrane transport,GO:0060539~diaphragm development,GO:0070207~protein homotrimerization,	GO:0016020~membrane,GO:0016323~basolateral plasma membrane,	GO:0005515~protein binding,GO:1904680~peptide transmembrane transporter activity,	IPR000731:SSD,IPR003392:Ptc/Disp,IPR052081:Dispatched_Hh_regulator,	hsa04340:Hedgehog signaling pathway,					KW-0472~Membrane,		KW-0732~Signal,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0217~Developmental protein,KW-9996~Developmental protein,	KW-0325~Glycoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:SSD,REGION:Disordered,TRANSMEM:Helical,
P49961	ectonucleoside triphosphate diphosphohydrolase 1(ENTPD1)	Homo sapiens		GO:0006338~chromatin remodeling,GO:0007155~cell adhesion,GO:0007596~blood coagulation,GO:0009134~nucleoside diphosphate catabolic process,GO:0070527~platelet aggregation,GO:0140588~chromatin looping,	GO:0005886~plasma membrane,GO:0005901~caveola,GO:0016020~membrane,GO:0070062~extracellular exosome,	GO:0003689~DNA clamp loader activity,GO:0003924~GTPase activity,GO:0004050~apyrase activity,GO:0004382~GDP phosphatase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0016787~hydrolase activity,GO:0016887~ATP hydrolysis activity,GO:0017110~nucleoside diphosphate phosphatase activity,GO:0017111~ribonucleoside triphosphate phosphatase activity,GO:0036384~CDP phosphatase activity,GO:0043262~ADP phosphatase activity,GO:0043273~CTPase activity,GO:0045134~UDP phosphatase activity,GO:0061775~cohesin loader activity,GO:0103023~ITPase activity,GO:0140584~chromatin extrusion motor activity,GO:0140665~ATP-dependent H3-H4 histone complex chaperone activity,GO:0140849~ATP-dependent H2AZ histone chaperone activity,GO:1990003~IDP phosphatase activity,GO:1990606~membrane scission GTPase motor activity,	IPR000407:GDA1_CD39_NTPase,	hsa00230:Purine metabolism,hsa00240:Pyrimidine metabolism,hsa01100:Metabolic pathways,hsa01232:Nucleotide metabolism,hsa05169:Epstein-Barr virus infection,	615683~Spastic paraplegia 64, autosomal recessive,				KW-0472~Membrane,	KW-0225~Disease variant,KW-0523~Neurodegeneration,KW-0890~Hereditary spastic paraplegia,	KW-0812~Transmembrane,KW-1133~Transmembrane helix,	KW-0067~ATP-binding,KW-0106~Calcium,KW-0460~Magnesium,KW-0547~Nucleotide-binding,	KW-0378~Hydrolase,	KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-1015~Disulfide bond,	ACT_SITE:Proton acceptor,CARBOHYD:N-linked (GlcNAc...) asparagine,LIPID:S-palmitoyl cysteine,TOPO_DOM:Cytoplasmic,TOPO_DOM:Extracellular,TRANSMEM:Helical,
Q7ZVR8	epithelial splicing regulatory protein 2(esrp2)	Danio rerio		GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0043484~regulation of RNA splicing,GO:1904888~cranial skeletal system development,GO:1905748~hard palate morphogenesis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:1990904~ribonucleoprotein complex,	GO:0003676~nucleic acid binding,GO:0003723~RNA binding,GO:0003729~mRNA binding,	IPR000504:RRM_dom,IPR012337:RNaseH-like_sf,IPR012677:Nucleotide-bd_a/b_plait_sf,IPR035979:RBD_domain_sf,IPR036397:RNaseH_sf,IPR050666:ESRP,				SM00360:RRM,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,		KW-0677~Repeat,		KW-0694~RNA-binding,		DOMAIN:RRM,DOMAIN:RRM 1,DOMAIN:RRM 2,DOMAIN:RRM 3,
Q90705	eukaryotic translation elongation factor 2(EEF2)	Gallus gallus	Translation, ribosomal structure and biogenesis,	GO:0006412~translation,GO:0006414~translational elongation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:1990904~ribonucleoprotein complex,	GO:0003746~translation elongation factor activity,GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0043022~ribosome binding,	IPR000640:EFG_V-like,IPR000795:T_Tr_GTP-bd_dom,IPR004161:EFTu-like_2,IPR005225:Small_GTP-bd_dom,IPR005517:Transl_elong_EFG/EF2_IV,IPR009000:Transl_B-barrel_sf,IPR014721:Ribsml_uS5_D2-typ_fold_subgr,IPR020568:Ribosomal_Su5_D2-typ_SF,IPR027417:P-loop_NTPase,IPR031157:G_TR_CS,IPR035647:EFG_III/V,IPR041095:EFG_II,				SM00838:EFG_C,SM00889:EFG_IV,	KW-0648~Protein biosynthesis,	KW-0539~Nucleus,KW-0963~Cytoplasm,			KW-0342~GTP-binding,KW-0547~Nucleotide-binding,	KW-0251~Elongation factor,KW-0378~Hydrolase,	KW-0597~Phosphoprotein,	DOMAIN:Tr-type G,DOMAIN:tr-type G,REGION:Disordered,
Q80U96	exportin 1(Xpo1)	Rattus norvegicus	Nuclear structure / Intracellular trafficking and secretion,	GO:0000054~ribosomal subunit export from nucleus,GO:0000055~ribosomal large subunit export from nucleus,GO:0000056~ribosomal small subunit export from nucleus,GO:0000122~negative regulation of transcription by RNA polymerase II,GO:0006406~mRNA export from nucleus,GO:0006611~protein export from nucleus,GO:0006913~nucleocytoplasmic transport,GO:0009410~response to xenobiotic stimulus,GO:0010824~regulation of centrosome duplication,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0034504~protein localization to nucleus,GO:0042176~regulation of protein catabolic process,GO:0042254~ribosome biogenesis,GO:0046825~regulation of protein export from nucleus,GO:0071401~cellular response to triglyceride,GO:1902075~cellular response to salt,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005642~annulate lamellae,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0015030~Cajal body,GO:0031965~nuclear membrane,GO:0032991~protein-containing complex,GO:0043231~intracellular membrane-bounded organelle,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0005049~nuclear export signal receptor activity,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0031267~small GTPase binding,GO:0140297~DNA-binding transcription factor binding,	IPR001494:Importin-beta_N,IPR011989:ARM-like,IPR013598:Exportin-1/Importin-b-like,IPR014877:XPO1_C_dom,IPR016024:ARM-type_fold,IPR040485:XPO1_repeat_3,IPR041123:CRM1_repeat,IPR041235:Exp1_repeat_2,IPR045065:XPO1/5,	rno03008:Ribosome biogenesis in eukaryotes,rno03013:Nucleocytoplasmic transport,rno03250:Viral life cycle - HIV-1,rno05164:Influenza A,rno05166:Human T-cell leukemia virus 1 infection,			SM00913:IBN_N,SM01102:CRM1_C,	KW-0509~mRNA transport,KW-0653~Protein transport,KW-0813~Transport,	KW-0539~Nucleus,KW-0963~Cytoplasm,		KW-0677~Repeat,		KW-0694~RNA-binding,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	DOMAIN:Exportin-1 C-terminal,DOMAIN:Importin N-terminal,REGION:Necessary for interaction with RANBP3,REGION:Necessary for interaction with Ran and nuclear export complex formation,REPEAT:HEAT 1,REPEAT:HEAT 10,REPEAT:HEAT 2,REPEAT:HEAT 3,REPEAT:HEAT 4,REPEAT:HEAT 5,REPEAT:HEAT 6,REPEAT:HEAT 7,REPEAT:HEAT 8,REPEAT:HEAT 9,
Q8AWC7	fucosyltransferase 11(FUT11)	Gallus gallus		GO:0006486~protein glycosylation,GO:0036065~fucosylation,	GO:0000139~Golgi membrane,GO:0032580~Golgi cisterna membrane,	GO:0046920~alpha-(1->3)-fucosyltransferase activity,	IPR001503:Glyco_trans_10,IPR017176:Alpha-1_3-FUT_met,IPR031481:Glyco_tran_10_N,IPR038577:GT10-like_C_sf,			PIRSF037332:Alpha1_3FUT_met,			KW-0333~Golgi apparatus,KW-0472~Membrane,		KW-0732~Signal,KW-0735~Signal-anchor,KW-0812~Transmembrane,KW-1133~Transmembrane helix,		KW-0328~Glycosyltransferase,KW-0808~Transferase,	KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Fucosyltransferase N-terminal,REGION:Disordered,TOPO_DOM:Cytoplasmic,TOPO_DOM:Lumenal,TRANSMEM:Helical; Signal-anchor for type II membrane protein,
A4IGM4	hydroxysteroid (11-beta) dehydrogenase 1-like(hsd11b1l)	Xenopus tropicalis	General function prediction only,		GO:0005576~extracellular region,GO:0043231~intracellular membrane-bounded organelle,	GO:0016491~oxidoreductase activity,	IPR002347:SDR_fam,IPR020904:Sc_DH/Rdtase_CS,IPR036291:NAD(P)-bd_dom_sf,IPR051253:11-beta-HSD,	xtr00140:Steroid hormone biosynthesis,xtr00980:Metabolism of xenobiotics by cytochrome P450,xtr01100:Metabolic pathways,					KW-0964~Secreted,		KW-0732~Signal,	KW-0521~NADP,	KW-0560~Oxidoreductase,		ACT_SITE:Proton acceptor,
Q7Z494	nephrocystin 3(NPHP3)	Homo sapiens	General function prediction only,Lipid metabolism,	GO:0001822~kidney development,GO:0001947~heart looping,GO:0003283~atrial septum development,GO:0006629~lipid metabolic process,GO:0007163~establishment or maintenance of cell polarity,GO:0007368~determination of left/right symmetry,GO:0016055~Wnt signaling pathway,GO:0030198~extracellular matrix organization,GO:0030324~lung development,GO:0035469~determination of pancreatic left/right asymmetry,GO:0045494~photoreceptor cell maintenance,GO:0048496~maintenance of animal organ identity,GO:0060026~convergent extension,GO:0060027~convergent extension involved in gastrulation,GO:0060271~cilium assembly,GO:0060287~epithelial cilium movement involved in determination of left/right asymmetry,GO:0060993~kidney morphogenesis,GO:0071908~determination of intestine left/right asymmetry,GO:0071909~determination of stomach left/right asymmetry,GO:0071910~determination of liver left/right asymmetry,GO:0072189~ureter development,GO:0090090~negative regulation of canonical Wnt signaling pathway,GO:1905515~non-motile cilium assembly,GO:2000095~regulation of Wnt signaling pathway, planar cell polarity pathway,	GO:0005576~extracellular region,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005871~kinesin complex,GO:0005874~microtubule,GO:0005929~cilium,GO:0097543~ciliary inversin compartment,GO:0097546~ciliary base,	GO:0005515~protein binding,	IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR027417:P-loop_NTPase,IPR051787:Effector/Ciliary-Dev_Assoc,IPR052752:NACHT-WD_repeat,		208540~Renal-hepatic-pancreatic dysplasia 1,267010~Meckel syndrome 7,604387~Nephronophthisis 3,		SM00028:TPR,	KW-0879~Wnt signaling pathway,	KW-0206~Cytoskeleton,KW-0493~Microtubule,KW-0963~Cytoplasm,KW-0966~Cell projection,KW-0969~Cilium,	KW-0225~Disease variant,KW-0981~Meckel syndrome,KW-0983~Nephronophthisis,KW-1186~Ciliopathy,	KW-0175~Coiled coil,KW-0677~Repeat,KW-0802~TPR repeat,		KW-0505~Motor protein,	KW-0449~Lipoprotein,KW-0519~Myristate,	COMPBIAS:Polar residues,LIPID:N-myristoyl glycine,REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 10,REPEAT:TPR 11,REPEAT:TPR 2,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,REPEAT:TPR 9,
Q8BHB0	nucleotide-binding oligomerization domain containing 1(Nod1)	Mus musculus		GO:0002221~pattern recognition receptor signaling pathway,GO:0002606~positive regulation of dendritic cell antigen processing and presentation,GO:0006915~apoptotic process,GO:0006952~defense response,GO:0007254~JNK cascade,GO:0010508~positive regulation of autophagy,GO:0010934~macrophage cytokine production,GO:0016045~detection of bacterium,GO:0032635~interleukin-6 production,GO:0032640~tumor necrosis factor production,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032755~positive regulation of interleukin-6 production,GO:0032757~positive regulation of interleukin-8 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0034976~response to endoplasmic reticulum stress,GO:0035556~intracellular signal transduction,GO:0042742~defense response to bacterium,GO:0043065~positive regulation of apoptotic process,GO:0043123~positive regulation of canonical NF-kappaB signal transduction,GO:0045087~innate immune response,GO:0046330~positive regulation of JNK cascade,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051403~stress-activated MAPK cascade,GO:0060907~positive regulation of macrophage cytokine production,GO:0070371~ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070427~nucleotide-binding oligomerization domain containing 1 signaling pathway,GO:0071225~cellular response to muramyl dipeptide,GO:0098792~xenophagy,GO:1901224~positive regulation of non-canonical NF-kappaB signal transduction,GO:1904417~positive regulation of xenophagy,GO:2001056~positive regulation of cysteine-type endopeptidase activity,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0016328~lateral plasma membrane,GO:0045335~phagocytic vesicle,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0038187~pattern recognition receptor activity,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0042834~peptidoglycan binding,GO:0043130~ubiquitin binding,GO:0044877~protein-containing complex binding,GO:0050700~CARD domain binding,	IPR001315:CARD,IPR001611:Leu-rich_rpt,IPR007111:NACHT_NTPase,IPR011029:DEATH-like_dom_sf,IPR027417:P-loop_NTPase,IPR032675:LRR_dom_sf,IPR041075:NOD1/2_WH,IPR041267:NLRP_HD2,IPR051261:NLR,IPR052201:LRR-containing_regulator,	mmu04621:NOD-like receptor signaling pathway,mmu05132:Salmonella infection,mmu05133:Pertussis,			SM00368:LRR_RI,	KW-0053~Apoptosis,KW-0391~Immunity,KW-0399~Innate immunity,	KW-0472~Membrane,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0433~Leucine-rich repeat,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,		KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0832~Ubl conjugation,	DOMAIN:CARD,DOMAIN:NACHT,LIPID:S-palmitoyl cysteine,REPEAT:LRR 1,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,
Q8K3Z0	nucleotide-binding oligomerization domain containing 2(Nod2)	Mus musculus		GO:0000165~MAPK cascade,GO:0001659~temperature homeostasis,GO:0002221~pattern recognition receptor signaling pathway,GO:0002227~innate immune response in mucosa,GO:0002250~adaptive immune response,GO:0002253~activation of immune response,GO:0002381~immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002606~positive regulation of dendritic cell antigen processing and presentation,GO:0002710~negative regulation of T cell mediated immunity,GO:0002720~positive regulation of cytokine production involved in immune response,GO:0002732~positive regulation of dendritic cell cytokine production,GO:0002815~biosynthetic process of antibacterial peptides active against Gram-positive bacteria,GO:0002830~positive regulation of type 2 immune response,GO:0002862~negative regulation of inflammatory response to antigenic stimulus,GO:0002925~positive regulation of humoral immune response mediated by circulating immunoglobulin,GO:0006909~phagocytosis,GO:0006914~autophagy,GO:0006952~defense response,GO:0006954~inflammatory response,GO:0006963~positive regulation of antibacterial peptide biosynthetic process,GO:0006965~positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,GO:0007165~signal transduction,GO:0007254~JNK cascade,GO:0007584~response to nutrient,GO:0008284~positive regulation of cell population proliferation,GO:0009595~detection of biotic stimulus,GO:0010508~positive regulation of autophagy,GO:0010646~regulation of cell communication,GO:0010934~macrophage cytokine production,GO:0010936~negative regulation of macrophage cytokine production,GO:0016045~detection of bacterium,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0023051~regulation of signaling,GO:0030277~maintenance of gastrointestinal epithelium,GO:0031398~positive regulation of protein ubiquitination,GO:0032088~negative regulation of NF-kappaB transcription factor activity,GO:0032098~regulation of appetite,GO:0032494~response to peptidoglycan,GO:0032495~response to muramyl dipeptide,GO:0032496~response to lipopolysaccharide,GO:0032498~detection of muramyl dipeptide,GO:0032609~type II interferon production,GO:0032615~interleukin-12 production,GO:0032621~interleukin-18 production,GO:0032623~interleukin-2 production,GO:0032635~interleukin-6 production,GO:0032640~tumor necrosis factor production,GO:0032689~negative regulation of type II interferon production,GO:0032695~negative regulation of interleukin-12 production,GO:0032701~negative regulation of interleukin-18 production,GO:0032703~negative regulation of interleukin-2 production,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032733~positive regulation of interleukin-10 production,GO:0032735~positive regulation of interleukin-12 production,GO:0032740~positive regulation of interleukin-17 production,GO:0032755~positive regulation of interleukin-6 production,GO:0032757~positive regulation of interleukin-8 production,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0034134~toll-like receptor 2 signaling pathway,GO:0034136~negative regulation of toll-like receptor 2 signaling pathway,GO:0034976~response to endoplasmic reticulum stress,GO:0035556~intracellular signal transduction,GO:0036335~intestinal stem cell homeostasis,GO:0042742~defense response to bacterium,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of canonical NF-kappaB signal transduction,GO:0043330~response to exogenous dsRNA,GO:0043410~positive regulation of MAPK cascade,GO:0045087~innate immune response,GO:0045088~regulation of innate immune response,GO:0045089~positive regulation of innate immune response,GO:0045747~positive regulation of Notch signaling pathway,GO:0045944~positive regulation of transcription by RNA polymerase II,GO:0046330~positive regulation of JNK cascade,GO:0048874~host-mediated regulation of intestinal microbiota composition,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050727~regulation of inflammatory response,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050766~positive regulation of phagocytosis,GO:0050830~defense response to Gram-positive bacterium,GO:0050871~positive regulation of B cell activation,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051403~stress-activated MAPK cascade,GO:0051649~establishment of localization in cell,GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process,GO:0060907~positive regulation of macrophage cytokine production,GO:0070371~ERK1 and ERK2 cascade,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070431~nucleotide-binding oligomerization domain containing 2 signaling pathway,GO:0071222~cellular response to lipopolysaccharide,GO:0071224~cellular response to peptidoglycan,GO:0071225~cellular response to muramyl dipeptide,GO:0071407~cellular response to organic cyclic compound,GO:0071608~macrophage inflammatory protein-1 alpha production,GO:0071639~positive regulation of monocyte chemotactic protein-1 production,GO:0090022~regulation of neutrophil chemotaxis,GO:0098792~xenophagy,GO:0140367~antibacterial innate immune response,GO:1900017~positive regulation of cytokine production involved in inflammatory response,GO:1901224~positive regulation of non-canonical NF-kappaB signal transduction,GO:1901526~positive regulation of mitophagy,GO:1902523~positive regulation of protein K63-linked ubiquitination,GO:1904417~positive regulation of xenophagy,GO:2000110~negative regulation of macrophage apoptotic process,	GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016323~basolateral plasma membrane,GO:0016328~lateral plasma membrane,GO:0019897~extrinsic component of plasma membrane,GO:0031982~vesicle,GO:0032991~protein-containing complex,GO:0045335~phagocytic vesicle,	GO:0003779~actin binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0030544~Hsp70 protein binding,GO:0032500~muramyl dipeptide binding,GO:0038187~pattern recognition receptor activity,GO:0042834~peptidoglycan binding,GO:0043130~ubiquitin binding,GO:0043531~ADP binding,GO:0044877~protein-containing complex binding,GO:0050700~CARD domain binding,GO:0051879~Hsp90 protein binding,GO:0097367~carbohydrate derivative binding,	IPR001315:CARD,IPR001611:Leu-rich_rpt,IPR007111:NACHT_NTPase,IPR011029:DEATH-like_dom_sf,IPR018228:DNase_TatD-rel_CS,IPR027417:P-loop_NTPase,IPR032675:LRR_dom_sf,IPR041075:NOD1/2_WH,IPR041267:NLRP_HD2,IPR051261:NLR,	mmu04621:NOD-like receptor signaling pathway,mmu04668:TNF signaling pathway,mmu05152:Tuberculosis,mmu05321:Inflammatory bowel disease,			SM00368:LRR_RI,	KW-0072~Autophagy,KW-0391~Immunity,KW-0399~Innate immunity,KW-1064~Adaptive immunity,	KW-0472~Membrane,KW-0496~Mitochondrion,KW-0963~Cytoplasm,KW-1003~Cell membrane,		KW-0433~Leucine-rich repeat,KW-0677~Repeat,	KW-0067~ATP-binding,KW-0547~Nucleotide-binding,		KW-0325~Glycoprotein,KW-0449~Lipoprotein,KW-0564~Palmitate,KW-0832~Ubl conjugation,	DOMAIN:CARD,DOMAIN:CARD 1,DOMAIN:CARD 2,DOMAIN:NACHT,LIPID:S-palmitoyl cysteine,MOTIF:ATG16L1-binding motif,MUTAGEN:LSRNSAILEVWLRGNTFSLEEIQTLSSRDARLLL->P: Mutation that mimics human L1007fsinsC variant; knockin mice show elevated NF-kappa-B activation in response to muramyl dipeptide and more efficient processing and secretion of the cytokine IL1B.,MUTAGEN:R->Q: Mutation that mimics a human variant associated with Blau syndrome (BLAUS); knockin mice show impaired response to muramyl dipeptide.,REGION:Required for CARD9 binding,REPEAT:LRR 1,REPEAT:LRR 10,REPEAT:LRR 2,REPEAT:LRR 3,REPEAT:LRR 4,REPEAT:LRR 5,REPEAT:LRR 6,REPEAT:LRR 7,REPEAT:LRR 8,REPEAT:LRR 9,
Q6V0K7	oncoprotein induced transcript 3(Oit3)	Rattus norvegicus		GO:0003014~renal system process,	GO:0005615~extracellular space,GO:0005635~nuclear envelope,GO:0009986~cell surface,	GO:0005509~calcium ion binding,GO:0005515~protein binding,	IPR000742:EGF-like_dom,IPR001507:ZP_dom,IPR001881:EGF-like_Ca-bd_dom,IPR042235:ZP-C,IPR048290:ZP_chr,				SM00179:EGF_CA,SM00181:EGF,SM00241:ZP,		KW-0539~Nucleus,		KW-0245~EGF-like domain,KW-0732~Signal,	KW-0106~Calcium,		KW-0325~Glycoprotein,KW-1015~Disulfide bond,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:EGF-like; calcium-binding,DOMAIN:ZP,REGION:Disordered,
Q7T0T9	phospholipase A2 group IVA L homeolog(pla2g4a.L)	Xenopus laevis		GO:0009395~phospholipid catabolic process,GO:0016042~lipid catabolic process,	GO:0005737~cytoplasm,GO:0031410~cytoplasmic vesicle,	GO:0004620~phospholipase activity,GO:0004622~lysophospholipase activity,GO:0004623~phospholipase A2 activity,GO:0005509~calcium ion binding,GO:0016787~hydrolase activity,GO:0046872~metal ion binding,GO:0047498~calcium-dependent phospholipase A2 activity,GO:0047499~calcium-independent phospholipase A2 activity,	IPR000008:C2_dom,IPR002642:LysoPLipase_cat_dom,IPR016035:Acyl_Trfase/lysoPLipase,IPR035892:C2_domain_sf,IPR041847:C2_cPLA2,	xla00564:Glycerophospholipid metabolism,xla00565:Ether lipid metabolism,xla00590:Arachidonic acid metabolism,xla00591:Linoleic acid metabolism,xla00592:alpha-Linolenic acid metabolism,xla01100:Metabolic pathways,xla04010:MAPK signaling pathway,xla04217:Necroptosis,xla04270:Vascular smooth muscle contraction,xla04370:VEGF signaling pathway,xla04912:GnRH signaling pathway,			SM00022:PLAc,SM00239:C2,	KW-0442~Lipid degradation,KW-0443~Lipid metabolism,	KW-0963~Cytoplasm,KW-0968~Cytoplasmic vesicle,			KW-0106~Calcium,KW-0479~Metal-binding,	KW-0378~Hydrolase,		ACT_SITE:Nucleophile,ACT_SITE:Proton acceptor,COMPBIAS:Basic and acidic residues,DOMAIN:C2,DOMAIN:PLA2c,REGION:Disordered,REGION:Phospholipid binding,
Q0VGM9	regulator of telomere elongation helicase 1(Rtel1)	Mus musculus		GO:0000723~telomere maintenance,GO:0000732~DNA strand displacement,GO:0006281~DNA repair,GO:0006338~chromatin remodeling,GO:0010569~regulation of double-strand break repair via homologous recombination,GO:0031297~replication fork processing,GO:0032206~positive regulation of telomere maintenance,GO:0032508~DNA duplex unwinding,GO:0043247~telomere maintenance in response to DNA damage,GO:0045910~negative regulation of DNA recombination,GO:0061820~telomeric D-loop disassembly,GO:0090657~telomeric loop disassembly,GO:0140588~chromatin looping,GO:1902990~mitotic telomere maintenance via semi-conservative replication,GO:1904355~positive regulation of telomere capping,GO:1904358~positive regulation of telomere maintenance via telomere lengthening,GO:1904430~negative regulation of t-circle formation,GO:1904506~negative regulation of telomere maintenance in response to DNA damage,GO:1904535~positive regulation of telomeric loop disassembly,	GO:0000781~chromosome, telomeric region,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0016607~nuclear speck,GO:0031965~nuclear membrane,	GO:0003677~DNA binding,GO:0003678~DNA helicase activity,GO:0003689~DNA clamp loader activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0009378~four-way junction helicase activity,GO:0016818~hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,GO:0016853~isomerase activity,GO:0016887~ATP hydrolysis activity,GO:0036121~double-stranded DNA helicase activity,GO:0046872~metal ion binding,GO:0051539~4 iron, 4 sulfur cluster binding,GO:0061749~forked DNA-dependent helicase activity,GO:0061775~cohesin loader activity,GO:0070182~DNA polymerase binding,GO:0140584~chromatin extrusion motor activity,GO:0140665~ATP-dependent H3-H4 histone complex chaperone activity,GO:0140849~ATP-dependent H2AZ histone chaperone activity,GO:1990518~single-stranded 3'-5' DNA helicase activity,	IPR006554:Helicase-like_DEXD_c2,IPR006555:ATP-dep_Helicase_C,IPR006935:Helicase/UvrB_N,IPR010614:RAD3-like_helicase_DEAD,IPR013020:Rad3/Chl1-like,IPR014013:Helic_SF1/SF2_ATP-bd_DinG/Rad3,IPR027417:P-loop_NTPase,IPR030845:RTEL1,IPR045028:DinG/Rad3-like,IPR049909:HHD_RTEL1,				SM00488:DEXDc2,SM00491:HELICc2,	KW-0227~DNA damage,KW-0234~DNA repair,	KW-0539~Nucleus,			KW-0004~4Fe-4S,KW-0067~ATP-binding,KW-0408~Iron,KW-0411~Iron-sulfur,KW-0479~Metal-binding,KW-0547~Nucleotide-binding,	KW-0238~DNA-binding,KW-0347~Helicase,KW-0378~Hydrolase,KW-0413~Isomerase,		COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:Helicase ATP-binding,MOTIF:DEAH box,MOTIF:Nuclear localization signal,MOTIF:PIP-box,MUTAGEN:F->A: Abolishes interaction with PCNA.,MUTAGEN:I->A: Abolishes interaction with PCNA.,MUTAGEN:K->R: Abolishes G4-DNA unwinding activity.,MUTAGEN:Q->A: Abolishes interaction with PCNA.,REGION:Disordered,
Q9NZJ4	sacsin molecular chaperone(SACS)	Homo sapiens	Posttranslational modification, protein turnover, chaperones,	GO:0006457~protein folding,GO:0090084~negative regulation of inclusion body assembly,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0030424~axon,GO:0030425~dendrite,GO:0070852~cell body fiber,	GO:0030544~Hsp70 protein binding,GO:0042802~identical protein binding,GO:0050750~low-density lipoprotein particle receptor binding,GO:0051087~protein-folding chaperone binding,GO:0070628~proteasome binding,	IPR000626:Ubiquitin-like_dom,IPR001623:DnaJ_domain,IPR007842:HEPN_dom,IPR029071:Ubiquitin-like_domsf,IPR036869:J_dom_sf,IPR036890:HATPase_C_sf,IPR052972:Sacsin_chaperone_reg,		270550~Spastic ataxia, Charlevoix-Saguenay type,		SM00748:HEPN,		KW-0963~Cytoplasm,	KW-0225~Disease variant,KW-0523~Neurodegeneration,			KW-0143~Chaperone,	KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:HEPN,DOMAIN:J,DOMAIN:Ubiquitin-like,REGION:Disordered,
Q9PV94	small nuclear ribonucleoprotein polypeptide N(SNRPN)	Gallus gallus		GO:0000387~spliceosomal snRNP assembly,GO:0000398~mRNA splicing, via spliceosome,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005682~U5 snRNP,GO:0005683~U7 snRNP,GO:0005684~U2-type spliceosomal complex,GO:0005685~U1 snRNP,GO:0005686~U2 snRNP,GO:0005687~U4 snRNP,GO:0005689~U12-type spliceosomal complex,GO:0005697~telomerase holoenzyme complex,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0034709~methylosome,GO:0034719~SMN-Sm protein complex,GO:0046540~U4/U6 x U5 tri-snRNP complex,GO:0071004~U2-type prespliceosome,GO:0071005~U2-type precatalytic spliceosome,GO:0071007~U2-type catalytic step 2 spliceosome,GO:0071013~catalytic step 2 spliceosome,GO:1990904~ribonucleoprotein complex,	GO:0003723~RNA binding,GO:0070034~telomerase RNA binding,GO:0070990~snRNP binding,	IPR001163:Sm_dom_euk/arc,IPR010920:LSM_dom_sf,IPR017131:snRNP-assoc_SmB/SmN,IPR047575:Sm,IPR050914:snRNP_SmB_SmN,	gga03040:Spliceosome,		PIRSF037187:snRNP_SmB/SmN,	SM00651:Sm,	KW-0507~mRNA processing,KW-0508~mRNA splicing,	KW-0539~Nucleus,KW-0747~Spliceosome,KW-0963~Cytoplasm,		KW-0677~Repeat,		KW-0687~Ribonucleoprotein,KW-0694~RNA-binding,		COMPBIAS:Pro residues,DOMAIN:Sm,REGION:Disordered,REGION:Repeat-rich region,
O43246	solute carrier family 7 member 4(SLC7A4)	Homo sapiens		GO:0006865~amino acid transport,GO:1990822~basic amino acid transmembrane transport,	GO:0005886~plasma membrane,GO:0016020~membrane,	GO:0015171~amino acid transmembrane transporter activity,GO:0015174~basic amino acid transmembrane transporter activity,GO:0022857~transmembrane transporter activity,	IPR002293:AA/rel_permease1,IPR029485:CAT_C,			PIRSF006060:AA_transporter,		KW-0029~Amino-acid transport,KW-0813~Transport,	KW-0472~Membrane,		KW-0812~Transmembrane,KW-1133~Transmembrane helix,			KW-0325~Glycoprotein,KW-0597~Phosphoprotein,	CARBOHYD:N-linked (GlcNAc...) asparagine,DOMAIN:Cationic amino acid transporter C-terminal,TRANSMEM:Helical,
Q96AY4	tetratricopeptide repeat domain 28(TTC28)	Homo sapiens		GO:0007346~regulation of mitotic cell cycle,GO:0051301~cell division,	GO:0000922~spindle pole,GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0030496~midbody,	GO:0019900~kinase binding,	IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR024983:CHAT_dom,IPR052699:Reg/Mitotic_Spindle_Assoc,				SM00028:TPR,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,		KW-0175~Coiled coil,KW-0677~Repeat,KW-0802~TPR repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Polar residues,DOMAIN:CHAT,REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 10,REPEAT:TPR 11,REPEAT:TPR 12,REPEAT:TPR 13,REPEAT:TPR 14,REPEAT:TPR 15,REPEAT:TPR 16,REPEAT:TPR 17,REPEAT:TPR 18,REPEAT:TPR 19,REPEAT:TPR 2,REPEAT:TPR 20,REPEAT:TPR 21,REPEAT:TPR 22,REPEAT:TPR 23,REPEAT:TPR 24,REPEAT:TPR 25,REPEAT:TPR 26,REPEAT:TPR 27,REPEAT:TPR 28,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,REPEAT:TPR 9,
Q80XJ3	tetratricopeptide repeat domain 28(Ttc28)	Mus musculus	Function unknown,	GO:0007346~regulation of mitotic cell cycle,GO:0051301~cell division,	GO:0005737~cytoplasm,GO:0005813~centrosome,GO:0030496~midbody,GO:0072686~mitotic spindle,GO:0097431~mitotic spindle pole,GO:1990023~mitotic spindle midzone,	GO:0019900~kinase binding,	IPR011990:TPR-like_helical_dom_sf,IPR019734:TPR_repeat,IPR024983:CHAT_dom,IPR052699:Reg/Mitotic_Spindle_Assoc,				SM00028:TPR,	KW-0131~Cell cycle,KW-0132~Cell division,KW-0498~Mitosis,	KW-0206~Cytoskeleton,KW-0963~Cytoplasm,		KW-0175~Coiled coil,KW-0677~Repeat,KW-0802~TPR repeat,			KW-0007~Acetylation,KW-0597~Phosphoprotein,	COMPBIAS:Basic and acidic residues,COMPBIAS:Polar residues,DOMAIN:CHAT,REGION:Disordered,REPEAT:TPR,REPEAT:TPR 1,REPEAT:TPR 10,REPEAT:TPR 11,REPEAT:TPR 12,REPEAT:TPR 13,REPEAT:TPR 14,REPEAT:TPR 15,REPEAT:TPR 16,REPEAT:TPR 17,REPEAT:TPR 18,REPEAT:TPR 19,REPEAT:TPR 2,REPEAT:TPR 20,REPEAT:TPR 21,REPEAT:TPR 22,REPEAT:TPR 23,REPEAT:TPR 24,REPEAT:TPR 25,REPEAT:TPR 26,REPEAT:TPR 27,REPEAT:TPR 28,REPEAT:TPR 3,REPEAT:TPR 4,REPEAT:TPR 5,REPEAT:TPR 6,REPEAT:TPR 7,REPEAT:TPR 8,REPEAT:TPR 9,
E7FAM5	tripartite motif containing 71, E3 ubiquitin protein ligase(trim71)	Danio rerio		GO:0000082~G1/S transition of mitotic cell cycle,GO:0000209~protein polyubiquitination,GO:0007399~nervous system development,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0010172~embryonic body morphogenesis,GO:0021915~neural tube development,GO:0035278~miRNA-mediated gene silencing by inhibition of translation,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0051865~protein autoubiquitination,GO:0072089~stem cell proliferation,GO:2000177~regulation of neural precursor cell proliferation,	GO:0000932~P-body,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0035198~miRNA binding,GO:0046872~metal ion binding,GO:0061630~ubiquitin protein ligase activity,	IPR000315:Znf_B-box,IPR001258:NHL_repeat,IPR001298:Filamin/ABP280_rpt,IPR001841:Znf_RING,IPR011042:6-blade_b-propeller_TolB-like,IPR013083:Znf_RING/FYVE/PHD,IPR013783:Ig-like_fold,IPR014756:Ig_E-set,IPR017868:Filamin/ABP280_repeat-like,IPR017907:Znf_RING_CS,IPR050952:TRIM-NHL_E3_ligases,				SM00184:RING,SM00336:BBOX,SM00557:IG_FLMN,	KW-0833~Ubl conjugation pathway,KW-0943~RNA-mediated gene silencing,	KW-0963~Cytoplasm,		KW-0175~Coiled coil,KW-0677~Repeat,KW-0863~Zinc-finger,	KW-0479~Metal-binding,KW-0862~Zinc,	KW-0217~Developmental protein,KW-0694~RNA-binding,KW-0808~Transferase,KW-9996~Developmental protein,		DOMAIN:B box-type,DOMAIN:RING-type,REGION:Disordered,REPEAT:Filamin,REPEAT:NHL,REPEAT:NHL 1,REPEAT:NHL 2,REPEAT:NHL 3,REPEAT:NHL 4,REPEAT:NHL 5,REPEAT:NHL 6,ZN_FING:B box-type 1; atypical,ZN_FING:B box-type 2,ZN_FING:RING-type,
